Advances in Current Diabetes Proteomics: From the Perspectives of Label-free Quantification and Biomarker Selection.

CONCLUSION: In summary, this review provides guidelines for researchers who will engage in proteomics biomarker discovery and by properly applying these proteomic computational advances, more reliable therapeutic targets will be found in the field of diabetes mellitus. PMID: 31433754 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31433754?dopt=Abstract

Source: Current Drug Targets - August 20, 2019 Category: Drugs & Pharmacology Authors: Fu J, Luo Y, Mou M, Zhang H, Tang J, Wang Y, Zhu F Tags: Curr Drug Targets Source Type: research